Login / Signup

Deferoxamine has the Potential to Improve the COVID-19-Related Inflammatory Response in Diabetic Patients.

Motahareh ZeinivandMasoomeh SharifiGholamhossein HassanshahiSeyed Ershad Nedaei
Published in: International journal of peptide research and therapeutics (2023)
Keyphrases
  • inflammatory response
  • coronavirus disease
  • sars cov
  • lipopolysaccharide induced
  • lps induced
  • toll like receptor
  • respiratory syndrome coronavirus
  • risk assessment
  • immune response